Live tape
Mentions 7d10,640MSFT2,124 mentions▲ +0.05META1,821 mentions▲ +0.06NVDA1,609 mentions▲ +0.09SKHYY1,174 mentions▲ +0.08GOOGL1,166 mentions▲ +0.04QQQ957 mentions▲ +0.06SNDK899 mentions▲ +0.08SPY890 mentions▲ +0.03
Equity · Healthcare

BLLN

BLLN · NasdaqGS
Price · Chart Chart by TradingView
Track this symbol on TradingView

Crowd sentiment on BLLN · 30d

Method · 0 mentions
Bullish 0%
Neutral 100%
Bearish 0%

Across 0 classified mentions in the last 30 days, crowd sentiment for BLLN sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.

BLLN insider trades

SEC Form 4
Date Insider Type Shares Value
06 Jul 2026 Atay Oguzhan Chairman and CEO OPTION EXERCISE 26,250 $74K
06 Jul 2026 Atay Oguzhan Chairman and CEO SELL 35,410 $4.32M
01 Jul 2026 Johnson Nancy JoAnn See Remarks SELL 801 $100K
29 Jun 2026 ten Bosch John Roderick SVP of Laboratory Operations SELL 1,416 $170K
24 Jun 2026 Sakakibara Shan Riku Chief Product Officer OPTION EXERCISE 4,000 $35K
24 Jun 2026 Sakakibara Shan Riku Chief Product Officer SELL 4,000 $440K
15 Jun 2026 ten Bosch John Roderick See Remarks SELL 1,416 $144K
15 Jun 2026 Tsao David Chief Technology Officer OPTION EXERCISE 10,000 $28K

BLLN earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.34 $108M
31 Dec 2025 FY 2025 $0.14 $305M
30 Sep 2025 Q3 2025 $0.10 $84M
31 Mar 2025 Q1 2026 $-0.39 $59M

Reported figures & scheduled dates · SEC EDGAR filings